Thiazolidinediones and Heart Failure
Author(s) -
Sonal Singh,
Yoon K. Loke,
Curt D. Furberg
Publication year - 2007
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc07-0141
Subject(s) - medicine , heart failure , observational study , randomized controlled trial , odds ratio , adverse effect , placebo , meta analysis , diabetes mellitus , cardiology , endocrinology , pathology , alternative medicine
Thiazolidinediones (TZDs) are known to increase the risk of heart failure in patients with type 2 diabetes. We aimed to evaluate the magnitude of the risk of heart failure with TZDs and classify this adverse effect under the novel dose-time-susceptibility system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom